CoChat

Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment

Open access

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Abstract

Sweat includes active components and metabolites, which are needed to maintain skin homeostasis. Component changes in sweat derived from atopic dermatitis (AD) have been reported. To investigate the influence of sweat components on the pathogenesis of AD, we performed a multifaceted assessment, including nuclear magnetic resonance spectroscopy-based metabolomic analysis, and linked these features to clinical features of AD. Distinctive properties of AD sweat are the quite-variation in protein, anti-microbial peptides and glucose concentrations. pH, sodium, and other salt levels in sweat of AD were comparable to that of healthy subjects. Sweat from AD patients with acute inflammation had a more prominent increase in glucose concentration than sweat from healthy individuals or those with AD with chronic inflammation. Topical glucose application delayed recovery of transepidermal water loss in barrier-disrupted mice. Furthermore, the glucose transporter GLUT2 was highly expressed in the lumen of sweat glands from AD patients. AD patients with chronic inflammation had significantly increased GLUT2 mRNA expression and near normal sweat glucose levels. Despite the small sample size in our study, we speculate that the increased glucose levels might be affected by AD severity and phenotype. We hope that this report will bring novel insight into the impact of sweat components on the clinical manifestation of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0195960

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 The properties of sweat from patients with atopic dermatitis (AD) and healthy subjects (HS). (a) Time required to obtain 5 ml of sweat (HS n = 10, AD n = 13). Analysis of: (b) pH (HS n = 10, AD n = 15); (c) protein concentration (HS n = 10, AD n = 17); (d) sodium concentration (HS n = 10, AD n = 14); and (e) other salt content (HS n = 9, AD n = 20). Concentration in sweat of anti-microbial peptides, including: (f) LL-37 (HS n = 6, AD n = 16); (g) dermcidin (HS n = 6, AD n = 17); and (h) β-defensin (HS n = 6, AD n = 17). F-test values represent individual variability within the sample.
Fig 1 The properties of sweat from patients with atopic dermatitis (AD) and healthy subjects (HS). (a) Time required to obtain 5 ml of sweat (HS n = 10, AD n = 13). Analysis of: (b) pH (HS n = 10, AD n = 15); (c) protein concentration (HS n = 10, AD n = 17); (d) sodium concentration (HS n = 10, AD n = 14); and (e) other salt content (HS n = 9, AD n = 20). Concentration in sweat of anti-microbial peptides, including: (f) LL-37 (HS n = 6, AD n = 16); (g) dermcidin (HS n = 6, AD n = 17); and (h) β-defensin (HS n = 6, AD n = 17). F-test values represent individual variability within the sample.CC BY · PubMed Central
Fig 2 NMR spectra of sweat from patients with AD and HS. (a) NMR spectra of the sweat from HS were characterized by intense lactate, pyruvate, and formate signals. A glucose peak was observed in sweat from AD. Glucose concentration was compared between (b) HS (n = 10) and AD (n = 21) and (c) between AD with eczema/exudative papules (ez/exu, n = 11), AD with lichenification/dermatitis (lich/der, (n = 10) and HS (n = 10). Key: (**p<0.01), unpaired t-test. (d) Correlation between disease severity (SCORAD) and properties of sweat. Statistical results are presented with Pearson’s correlation coefficients: pH, n = 16; protein concentration, n = 18; glucose concentration, n = 21; β-defensin, n = 18; and LL-37, n = 16.
Fig 2 NMR spectra of sweat from patients with AD and HS. (a) NMR spectra of the sweat from HS were characterized by intense lactate, pyruvate, and formate signals. A glucose peak was observed in sweat from AD. Glucose concentration was compared between (b) HS (n = 10) and AD (n = 21) and (c) between AD with eczema/exudative papules (ez/exu, n = 11), AD with lichenification/dermatitis (lich/der, (n = 10) and HS (n = 10). Key: (**p<0.01), unpaired t-test. (d) Correlation between disease severity (SCORAD) and properties of sweat. Statistical results are presented with Pearson’s correlation coefficients: pH, n = 16; protein concentration, n = 18; glucose concentration, n = 21; β-defensin, n = 18; and LL-37, n = 16.CC BY · PubMed Central
Fig 3 Impact of glucose on recovery of damaged stratum corneum in mice. (a) Time course for measuring transepidermal water loss (TEWL) following tape stripping in the barrier disruption mouse model. (b) Changes in the TEWL value during the time course. Red triangles represent the glucose-treated group (n = 3), blue squares represent the vehicle-treated group (n = 3), and black circles represent the control group (n = 3). Error bars indicate mean ± SD. Key: (***) p<0.001 (glucose vs. control), (*) p<0.05 (glucose vs. water), Tukey’s multiple comparison. DDW, distilled deionized water; TS, tape stripping. These results are from one independent experiment; another is shown in S1 Fig.
Fig 3 Impact of glucose on recovery of damaged stratum corneum in mice. (a) Time course for measuring transepidermal water loss (TEWL) following tape stripping in the barrier disruption mouse model. (b) Changes in the TEWL value during the time course. Red triangles represent the glucose-treated group (n = 3), blue squares represent the vehicle-treated group (n = 3), and black circles represent the control group (n = 3). Error bars indicate mean ± SD. Key: (***) p<0.001 (glucose vs. control), (*) p<0.05 (glucose vs. water), Tukey’s multiple comparison. DDW, distilled deionized water; TS, tape stripping. These results are from one independent experiment; another is shown in S1 Fig.CC BY · PubMed Central
Fig 4 GLUT2 localization in skin from patients with AD. The localization of GLUT2 (red) and smooth muscle actin (SMA; green) in healthy subjects (n = 3), patients with prurigo nodularis (n = 3), psoriasis (n = 3), AD with eczema/exudative papules (n = 8), or AD with dermatitis/lichenification (n = 3) as determined using immunofluorescence. Hoechst33322 was used to stain nuclei (blue). Representative data are presented. Scale bars are 100 μm.
Fig 4 GLUT2 localization in skin from patients with AD. The localization of GLUT2 (red) and smooth muscle actin (SMA; green) in healthy subjects (n = 3), patients with prurigo nodularis (n = 3), psoriasis (n = 3), AD with eczema/exudative papules (n = 8), or AD with dermatitis/lichenification (n = 3) as determined using immunofluorescence. Hoechst33322 was used to stain nuclei (blue). Representative data are presented. Scale bars are 100 μm.CC BY · PubMed Central
Fig 5 Expression of GLUT2 in sweat glands isolated from human skin. (a) Hematoxylin and eosin staining of LMD-harvested sweat glands. (b) GLUT2 mRNA was significantly increased in sweat glands from patients with AD (n = 11) compared with those from HS (control; n = 8). (C) GLUT2 mRNA expression was compared between samples of AD with eczema/exudative papules (n = 6) and AD with dermatitis/lichenification (n = 5). Key: (***) p<0.001, unpaired t-test.
Fig 5 Expression of GLUT2 in sweat glands isolated from human skin. (a) Hematoxylin and eosin staining of LMD-harvested sweat glands. (b) GLUT2 mRNA was significantly increased in sweat glands from patients with AD (n = 11) compared with those from HS (control; n = 8). (C) GLUT2 mRNA expression was compared between samples of AD with eczema/exudative papules (n = 6) and AD with dermatitis/lichenification (n = 5). Key: (***) p<0.001, unpaired t-test.CC BY · PubMed Central
Fig 6 Illustration of the sweat collection procedure. Briefly, the whole back was wiped with tap water (STEP 1), and a drape with a 15×20 cm square hole was applied (STEP 2). Petrolatum was applied to the area in the hole (STEP 3). The bottom of the drape was folded up to create a pocket for fluid collection as subjects bathed in a sauna at 80°C (STEP 4). The sweat that pooled in the drape was collected with a syringe and filtered with a cartridge-type 0.22-μm filter.
Fig 6 Illustration of the sweat collection procedure. Briefly, the whole back was wiped with tap water (STEP 1), and a drape with a 15×20 cm square hole was applied (STEP 2). Petrolatum was applied to the area in the hole (STEP 3). The bottom of the drape was folded up to create a pocket for fluid collection as subjects bathed in a sauna at 80°C (STEP 4). The sweat that pooled in the drape was collected with a syringe and filtered with a cartridge-type 0.22-μm filter.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 48

Metadata

Authors
Ono, E., Murota, H., Mori, Y., Yoshioka, Y., Nomura, Y., Munetsugu, T., Yokozeki, H., & Katayama, I.
Affiliations
  • The University of Osaka (JP)
  • Immunology Frontier Research Center, The University of Osaka (JP)
  • Tokyo Medical and Dental University (JP)
Corresponding author
Murota, Hiroyuki
Venue
PLOS ONE
Published
2018-04-20
Volume
13
Issue
4
Pages
e0195960
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2802326374
Cited by
46
References
31
Citations by year
2026: 2 · 2025: 4 · 2024: 6 · 2023: 8 · 2022: 8 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 1
FWCI
4.60
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • Japan Society for the Promotion of Science (17K07591)
  • Maruho Takagi Dermatology Foundation (https://www.mt-hifukagaku.or.jp/news/pdf/20170331mtf-os.pdf)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
Keywords
atopic dermatitis, sweat glucose, GLUT2, sweat glands, transepidermal water loss, skin barrier disruption, chronic inflammation, acute inflammation, antimicrobial peptides, disease severity
MeSH terms
Adolescent, Adult, Aged, Dermatitis, Atopic, Female, Glucose, Humans, Male, Middle Aged, Severity of Illness Index, Sweat, Sweat Glands, Up-Regulation, Case-Control Studies, Glucose Transporter Type 2, Metabolomics, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment. https://app.cochat.ai/papers/10.1371/journal.pone.0195960
The paper
Ono, E., Murota, H., Mori, Y., Yoshioka, Y., Nomura, Y., Munetsugu, T., Yokozeki, H., & Katayama, I. (2018). Sweat glucose and GLUT2 expression in atopic dermatitis: Implication for clinical manifestation and treatment. PLOS ONE. https://doi.org/10.1371/journal.pone.0195960

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.